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Background: Osteoarthritis is a widespread highly painful disabling age-related disease with no 
known cure. Although novel strategies for ameliorating osteoarthritic damage abound, it is likely 
that none will be successful over time if the entire spectrum of the disease and the effects of joint 
biomechanics on joint tissues are not carefully considered. Objectives: 1) To detail the structure of 
healthy articular cartilage, the key tissue affected by osteoarthritis. 2) To detail what aspects of 
cartilage damage best characterize osteoarthritis. 3) To consider the role of biomechanical factors 
in developing solutions to treat osteoarthritic joint damage. Methods: Literature sources from 
1980 onwards that have contributed to our knowledge of the topics relevant to this paper were 
accessed and retrieved. The data were categorized into four predominant themes and conclusions 
about the state of our knowledge and future directives were formulated. Conclusions: Osteoar- 
thritis prevalence remains high, and a cure appears elusive. A rich body of data has helped us to 
better understand the key tissue involved, and suggests a repair process might be feasible, if the 
basic collective information on the role of biomechanics in mediating or moderating articular car-
tilage integrity and function is forthcoming. 
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life quality throughout the world, affecting several million people [1]. Principally affecting the biomechanical 
and structural properties of focal regions of the articular cartilage tissue found covering the ends of bones within 
synovial joints, this debilitating arthritic condition develops slowly over several decades [1] and produces sub-
stantial degrees of chronic unrelenting progressive disability in adults over age 65 [2]. In addition to focal dam-
age of the articular tissue which usually progresses to involve the tissue as a whole, OA is usually characterized 
by detrimental physiological changes of the underlying subjacent bone, as well as the surrounding muscles and 
soft tissues of the joint [3]. Alone or in combination, all these changes can reduce the ability of the affected joint 
to absorb joint stresses, and the resultant damage to the joint may consequently severely impair an individuals’ 
ability to carry out his/her normal functions of daily living without compromise, effort and excessive physical 
stress.  
Although little is known about the precise cause of the most common and primary form of OA despite much 
research, one potential cause of the disease and its associated pathogenic mechanisms, aberrant joint biome-
chanics may play a considerable role in mediating osteoarthritic joint changes and in preventing treatments de-
signed to improve joint status from having long-term rather than short-term beneficial effects. To improve our 
understanding of why it is important to acknowledge the role of biomechanical forces in mediating this disease, 
the present paper attempts to summarize some of the more pertinent advances in our understanding of the com-
plex molecular anatomy and physiology of articular cartilage, the primary tissue affected in OA, and how joint 
mechanics might have a definite bearing on both causing OA as well as relative failure of attempts to reverse or 
ameliorate the condition. Finally, the implications of this information for the treatment and prevention of OA are 
addressed and suggestions are given for some future directions in this important field. Although damage to ex-
traarticular tissues and structures are clearly involved in the osteoarthritic process [3], the present discussion is 
largely restricted to a discussion of articular cartilage a primary site of osteoarthritic damage. Osteoarthritis is an 
extremely disabling disease, and affects millions of people worldwide. Since there is no current cure for OA and 
treatments advocated are not always successful, and are reported in some cases to exacerbate the problem, there 
is a clear need to continue to examine options for both prevention and intervention that can reduce the burden of 
the disease. Biomechanical factors are often cited as being important in explaining OA pathology, but are not 
always incorporated into the solutions advocated for alleviating the prevailing pain and dysfunction. 
1.1. Methods 
Literature sources from 1980 onwards that have contributed to our knowledge of the topics relevant to this paper 
were accessed and retrieved. The data bases used were pubmed, medline, cinahl, cochrane, academic search 
premier, and web of science. The key words employed were articular cartilage, biomechanics, and osteoarthri-
tis. Only those papers that focused on the specific topic and the review aims were included. All salient papers 
were read thoroughly and the relevant information was then either tabulated or incorporated into the document. 
The data were categorized into four predominant themes and conclusions about the state of our knowledge and 
future directives were formulated. The focus was on English language papers. 
1.2. Key Objectives 
The key objectives of this review were: to detail the structure of healthy articular cartilage, the key tissue af-
fected by osteoarthritis; to detail what aspects of cartilage damage best characterize osteoarthritis; and to con-
sider the role of biomechanical factors in developing solutions to treat osteoarthritic joint damage. 
2. Articular Cartilage 
2.1. General Structure 
Under normal physiological conditions, the bony surfaces of all freely moving adult synovial joints are protected 
by a thin, translucent layer of connective tissue, known as hyaline articular cartilage. Approximately 0.5 - 7 mm 
thick, the key components of articular cartilage are: 1) water which comprises 65 - 80 percent of its wet weight; 
2) reinforced collagen which comprises 10 - 30 percent of its net weight; 3) proteoglycan molecules which 
comprise 5 - 10 percent of its wet weight; 4) cells known as chondrocytes (comprising 1 - 10 percent of the car-
tilage volume); and 5) small amounts of other noncollagenous proteins, glycoproteins and lipids [4].  





conditions [5], and light and electron microscopic studies of articular cartilage have revealed the existence of a 
complex layered tissue made up of those constituents mentioned above, in various degrees. As such, the tissue 
itself can be differentiated broadly into an uncalcified tissue zone and a zone of calcified tissue, which are sepa-
rated by an irregular zone known as the tidemark. The uncalcified zone is made up of three different types of 
constituent arrangements as follows: 1) a thin superficial zone constituting approximately two percent of carti-
lage height that is in contact with the synovial cavity; 2) a deeper transitional zone constituting approximately 
five percent of cartilage height; 3) a third deeper basal or radial zone constituting approximately 92 percent of 
cartilage height. Beneath this radial zone, and separated from the uncalcified superficial, middle and deep zones 
by the tidemark is the zone of calcified cartilage [6]. This calcified cartilage zone lies above the subjacent sub-
chondral bone [7] from which it is delineated by a cement line [8] (See Figure 1). All these zones while clearly 
differentiated are equally important in the ability to protect adjacent bone surfaces as well as the interior of the 
articular tissue from excessive forces, especially those that might disrupt the viability of the chondrocytes di-
rectly, as well the tissue content surrounding these. 
2.2. Cartilage Constituents 
1) Chondrocytes 
As revealed by microscopy, cartilage chondrocytes are heterogeneous in shape as well as in function [7]. As 
the architects of cartilage [9], they are crucial to the viability of the tissue, and whether present as single units, 
double or multiple linear units, chondrocytes need to be protected from excessive joint forces and/or harmful 
chemical substrates, in order to function physiologically. In this regard, they are characteristically surrounded by 
a pericellular or lacunar area whose rich matrix forms a glycocalyx or capsular type structure containing a com-
bination of non-fibrillar collagens such as type IX, non-collagenous proteins such as fibronectin, link protein and 
laminen, proteoglycans such as hyaluronin and biglycan and a capsule constituted by type II, type VI and type 
XI collagen fibres [8] [10]. This basket-like network of fine fibrils is termed a chondron [9]. The chondrocytes, 
in turn are attached to this surrounding matrix and capsule partly through cytoskeletal microfilaments, such as 
alpha-actinin, talin, and vinculin microfilaments, and partly through cell membrane receptors constituted by 
glycoproteins such as anchorin II and chondronectin [11] and cell surface adhesion molecules such as CD44 
[12]. These receptors are highly sensitive to the mechanical and hydrostatic forces to which they are subject [13] 
and include those for fibronectin, and type II collagen fragments. 
Thus, whether they contain only one isolated chondrocyte or several, the chondrons help to protect the chon-
drocytes by dampening the forces falling on the tissue during dynamic loading [14]. More specifically, they 
permit forces falling on the chondrocyte cell membrane, a fluid mosaic composed of large proteins embedded in 
a thin planar bilayer of aliphatic phospholipid molecules, and comprised by specialized channels and a family of 
membrane receptors known as integrins [15] to be carefully transmitted and to thereby regulate the flow of nu-  
 
 
Figure 1. Diagrammatic representation of cartilage structure as outlined 





trients from the surrounding joint matrix and fluid to the interior of the chondrocyte. Chondrocytes can thus 
perceive physical signals from their surrounding environment that can have genetic and molecular influences 
[16]. In addition, by serving as mechanical, electrical and chemical transducers, these membrane channels and 
receptors, which are selectively sensitive to specific matrical ion and protein (ligands) constituents transport 
those substrates that mediate profound cellular effects such as proteoglycan synthesis [17]-[19], collagen type II 
synthesis and cartilage differentiation [15].  
While physiologically normal pressures placed on the joint surface can promote cartilage viability [5], unex-
pected or prolonged alterations from normal pressure can alter chondrocyte gene expression in an unfavourable 
way [20].  
2) Extracellular matrix 
The matrical tissue surrounding the cartilage chondrocytes or extracellular matrix, can be differentiated cir- 
cumferentially into a pericellular region, a territorial matrical area surrounding this and thereafter, by varying 
expanses of interterritorial matrix [8]. This matrix framework, which protects the chondrocytes from the harmful 
effects of excessive loading impactsis composed largely of water, and a proteoglycan called aggrecan that forms 
the bulk of the articular tissue, along with a variety of collagens, glycoproteins and noncollagenous proteins.  
The hydrous or water component of articular cartilage which forms its major constituent, contains gases, 
small proteins, metabolites, and a high concentration of positive ions or cations. While much of this water is 
bound to the proteoglycan and collagen molecules mentioned above, at least some of this water can move freely 
in and out of the tissue [19]. The resultant alterations in tissue ionic content and degree of resulting osmolarity 
that occurs due to changes in ionic concentration as a result of the movement of water in response to loading and 
unloading of the joint are of high import in the maintenance of the tissues’ load bearing properties [21]. 
The two classes of proteoglycans that constitute the bulk of articular cartilage, the aggrecans and small non- 
aggregating proteoglycans, including biglycan, fibromodulin, and decorin [21] contain extensive negatively 
charged side-chains constituted by two glycosaminoglycans, chondroiten sulphate and keratin sulphate. These 
disaccaride constituents of aggrecan are bound co-valently to a protein core by link protein and to strands of 
hyaluronic acid, another proteoglycan to form stable matrical aggregates [22] (See Figure 2). These disaccaride 
units, which are associated with negatively charged carboxyl or sulphate groups and whose side chains repel 
each other, tend to attract cations including water molecules. This ability to bind water plays a fundamental role 
in facilitating load transmission, and chondrocyte function [5]. 
In addition to aggrecan, vital to the structural integrity of articular cartilage is type II collagen, which exhibits 
a highly differential degree of ordering within the articular tissue consisting of: 1) fine collagen fibrils located at 
the articular tissues surface which are arranged tangentially, thick collagen bundles lying subjacent and parallel 
to its surface, 2) coarse radially oriented bundles forming a meshwork in the intermediate or transitional zone of  
 
 
Figure 2. Graphic representation of structure of proteoglycan mole-
cules of articular cartilage as adapted by the author from Aigner et al. 





articular cartilage, 3) random or coiled radial fibres in the deep zone which link the uncalcified cartilage to the 
underlying calcified cartilage, and 4) vertical fibres in the calcified cartilage which link the cartilage to the un-
derlying subchondral bone [19].  
The integrity of this collagen mesh, differentially ordered to conform with the concentric cartilage subdivi-
sions observed in the horizontal plane [8], is maintained by interlinking molecules such as type IX collagen, 
and/or by viscous forces between the fibrils and surrounding ground substance [19]. Although highly resistant to 
enzymatic cleavage with an extremely slow metabolism, cartilage collagen is readily digested by enzymes such 
as metalloproteases and cathepsins. On excessive exposure to such degradative enzymes, numbers of type II 
collagen fibres may be reduced, as may cartilage integrity, and the normal production of Type IX, XI, XII, V 
and VI cartilage collagens may be diminished. 
In general however, collagen interacts closely with the proteoglycans of the matrix and this restraining 
meshwork, contributes to the unique loading properties of cartilage tissue [8] [21] and may help to restrict col-
lagen fibrillogenesis, and influence chondrocyte cell function [8] [21], and the forces acting on cartilage must 
fall within a range suited to the continued vitality and viability of the cartilage cells [23], as well as the collagen 
framework. That is, they must be of sufficient amplitude to provide for a nutritional supply from synovial fluid 
to the avascular chondrocyte matrix, but must not be excessive so as to produce cellular or matrix necrosis. 
Where mechanical stress on the cartilage falls outside the optimum range, degenerative processes may be ex-
pected to ensue, regardless of age, and growth hormone availability. This may involve mechanical damage to the 
collagen meshwork, proteoglycan dysfunction, chondrocyte metabolic alterations, and/or synovial degradative 
enzyme production.  
3. Osteoarthritic Cartilage 
Various studies have attempted to examine processes that lead to articular cartilage destruction in both human 
and animal model contexts. In animal models as well as in human OA, researchers have observed that increased 
hydration of the cartilage matrix, an early and key event, may follow disruption of type II, type IV and/or type 
IX collagen fibres as a result of aging and fatigue failure, synovium and/or chondrocyte mediated enzymatic 
degradation of collagen [24] [25]. As well, debonding of the collagen-proteglycan interface leading to swelling 
of the cartilage matrix could reduce the stiffness of the tissue without any collagen network disruption [26]. 
Overall, the disruption of collagen fibres and/or collagen crosslinks from any cause is likely to deplete the elas-
ticity of cartilage, and reduce its resistance to weightbearing [27], while facilitating fragmentation of the carti-
lage proteoglycans which causes secondary inflammatory and degradative sequelae.  
As well as the disruption of type II collagen, and type IX collagen [24], traces of collagen Type I, variants of 
collagen Type II [7] and Type X collagen and Type I and III collagens, proteoglycans with an atypical glycosa-
minoglyan content may contribute to osteoarthritic joint disease [28]. In this respect, Type X collagen which is 
not normally found in healthy uncalcified cartilage, and is unable to form a fibrillar meshwork comparable to 
that of Type II/IX/XI collagen, may weaken the loading capacity of the articular cartilage matrix, perhaps pre-
paring it for, or contributing to, it’s excessive hydration and/or calcification.   
Also damaged may be fine collagen filaments containing Types VI and IX collagen located at the pericellular 
level, together with proteoglycans and collagen that protect the chondrocyte from stress. The pericellular fibrils 
while normally deficient towards the surface of the articular tissue forming pericellular channels between the 
general matrix and the lacunae surrounding the chondrocyte [29] may thus lose their ability to afford protection 
of cytoplasmic organelles from extraneous mechanical forces. Alterations in transduction processes across the 
cell membrane by virtue of these changes in pericellular collagen, as well as direct damage to the glycoproteins, 
anchorin and chondronectin and the integrins, which are possible mechanotransducers in addition to promoting 
cell adhesion may further disrupt cartilage contiguity.  
In addition to disruption of the predominant proteoglycan mediating the absorption of joint stresses, namely 
aggrecan, the synthesis of two smaller proteoglycan units found in articular cartilage, namely decorin located on 
the surface of the collagen fibers and biglycan which may be involved in the inhibition of cell adhesion and mi-
gration [11] may be impaired with deleterious consequences. Accompanying these changes may be excessive 
degradative enzyme production, which further damages collagenous and non-collagenous matrix constituents 
and promotes catabolic activation [9]. The articular cartilage matrix normally partly constituted by collagen ar-
cades and meshwork which controls loading responses and the diffusion of metabolic solutes into and from the 





Other research shows that any disruption of the adhesive associations between the chondrocyte and its 
pericellular matrix for example by dissociation of fibronectin may produce a phenotypic transformation of the 
chondrocyte cell and an alteration in its metabolic state [30], with higher rates of production of proteoglycan, 
hyaluronate and specifically the fibronectins [31] and COMP non-collageous proteins [32]. This hypermetabolic 
state may represent an attempt by the chondrocyte to mediate cartilage repair.   
However, due to their great affinity for water, the increased deposition of proteoglycan molecules that can 
ensue could cause further cartilage loading impairments [33]. As well, increases in the rate of proteoglycan syn-
thesis with length modifications which increases their hydrodynamic size plus synthesis of chondroiten sulphate 
chains which differ structurally from normal chains have been observed [34] and this altered conformation of 
the hydrophilic proteoglycans may permit their further hydration [35]. 
In addition to the cartilage thus formed being less suitable for its physiological role, fibronectin a matrix 
molecule which has a broad range of cellular functions including repair and assembly of cartilage oligomeric 
high-Mr matrix protein (COMP) and thromboplastin [4], may be disassociated. At the same time, the three 
long-chain proteoglycan molecules, namely, chondroitin-4-sulphate, chondroitin 6-sulphate and keratin sulphate 
normally assymetrically distributed and covalently bound to a protein core and long filaments of hyaluronic acid 
may be replaced by disaggregated proteoglycans of immature quality despite their increasing production. This 
may be due to structural defects in link protein and/or the G1 or globular domain of the protein core of aggrecan 
which interacts noncovalently with hyaluronic acid [11]. The hyaluronic acid backbone of osteoarthritic carti-
lage, may also be structurally modified despite its increasing production. The disaggregated matrical proteogly-
can complexes, no longer able to effectively constrain water within the fragmented and fibrillated collagen 
meshwork, may not protect the matrix against loading stresses, at all adequately [36]. The abnormal proteogly-
can fragments may also fail to interact optimally with intact collagen fibres thus reducing the ability of the tissue 
to protect the joint from excessive shear and compressive joint stresses [37]. 
As well as the abovementioned deleterious processes, biomechanical damage to the phospholipid membrane, 
the destruction of surface receptors for hyaluronan and interleukin antagonist receptors, plus the release of pros-
taglandins which stimulates protease activity may initiate a further degradative cascade along with damage to 
intracellular chondrocyte component [5] [38]. A similar cascade could occur due to biomechanically induced 
microfractures in the subchondral bone in response to aberrant joint loading which vascularises the cartilage and 
reduces the efficacy of protease (tissue inhibitor metalloproteinases TIMP) and endothelial-cell growth factor 
inhibitors [39]. 
4. Possible Pathogenic Pathways Involved in Osteoarthritis 
While the most likely event producing osteoarthritic damage is unclear, altered cell-matrix interactions and/or 
disruption of the extracellular matrix molecules, and the consequent failure of newly formed proteoglycans and 
hyaluronate to aggregate seem to play a major role. While damage may be caused by trauma, or overloading of 
normal or abnormal cartilage, the presence of persistent abnormal joint mechanics that can result regardless of 
the actual cause of the problem, is likely to interact adversely with the damaged tissue in terms of preventing 
aggregation-or causing defects in link protein molecules and the binding of hyaluronate to aggrecan molecules.  
The precise structure of the newly formed aggrecan and hyaluronate molecules may also be abnormal due to 
stress-induced alterations in chondrocyte genetics, precluding their effective aggregation. Thus the cartilage so 
formed may not effectively absorb high contact stresses consequent to mechanical loading, particularly if this is 
excessive in magnitude and/or duration, or suboptimal, thus negatively impacting adequate chondrocyte nutri-
tion, as well on the intact extracellular proteoglycan-hyaluronic acid and collagen complexes and their chondro-
cyte adhesions.  
Moreover, as with chondrocytes exposed to cell cultures devoid of extracellular matrix, the chondrocytes in 
these areas of matrical damage may undergo mitotic changes and/or migrate to form clones [40]. That is, they 
may proceed to carry out an attempted reparative process as suggested by Brocklehurst et al. [41], but although 
increased in number, may actually dedifferentiate. With their synthetic capability modified, immature, rather 
than mature, cartilage contents may develop. Altered as well, may be the balance of enzymes which normally 
inhibit catabolism-especially collagen cleavage, such as the Tissue Inhibitors of Metalloproteases (TIMPS) and 
its antagonistic Interleuken-1 receptors (Il-1 RA), and possibly some component of the Transforming Growth 





synovial cell tissue metalloproteases, elastases, stromelysin enzymes, aggrecanases, and collagenases, stromal 
cell derived factor-1 (SDF-1) [42], possibly in an attempt to catabolize the altered collagen being produced, or 
because synovial membrane inhibitors (e.g. catabolin) are depleted.  
Alternatively, neovascularisation from the underlying bone [24] may activate previously inactive cytokines 
[24] as might destructive alterations in Interleukin (IL)-6 and its soluble cell membrane receptor [43] causing 
pain, swelling, and stiffness [13]. Roughley et al. [44] reported that osteoarthritis appears to be associated with-
proteolytic degradation of its constituent proteoglycan aggregates, and that degradative changes in link protein 
have been characterized. Although Sokoloff argued that it is difficult to identify abnormalities confined to the 
cartilage as being solely responsible for OA [45], direct trauma affecting the chondrocyte cell membrane, may 
increase prostaglandin E activity and protease synthesis [38], and if pressure on the chondrocyte is not normal-
ized, research by Benya and Shaffer [46] suggests the normal phenotype may be lost and replaced by a complex 
collagen phenotype consisting predominately of type I collagen and a low level of proteoglycan synthesis. Ac-
cording to a review by Mobasheri et al. [47] these types of cartilage alterations can foster synovial inflammation, 
creating a vicious circle of joint degradation. Ultimately, the fragmentation of the proteoglycans and their resul-
tant inferior structure may stem from direct damage to intracellular structures such as microtubules and the golgi 
apparatus. A synovial inflammatory response which compounds this situation would be expected to produce a 
further cascade of destruction and ultimate death of viable chondrocytes due to release of nitric oxide, hydroxyl 
and superoxide radicals and with this more widespread cartilage damage and erosion. This is supported by find-
ings of Petterson et al. [48] that human chondrocytes express receptors mediating apoptosis and can be subject 
to cell death after exposure to tumor necrosis factor alpha. These researchers further suggested that these death 
receptors and their respective ligands may play a crucial rule in both cartilage generation as well as destruction. 
However, since most afflicted individuals will at this stage be experiencing pain and receiving medications to 
control their pain and inflammation, the likelihood exists that any primary causative factor underlying the condi-
tion, such as abnormal prolonged high intensity joint loading that can increase the expression of inflammatory 
mediators [5], will simply be overlooked and further aberrant loading will ensue, thus perpetuating the problem 
as outlined in Figure 3 as indicated by genetic models that show altered biomechanics alone can produce spon-
taneous or accelerated OA [13]. Untreated, this situation is hence likely to contribute to the diseases’ progress-  
 
 





sion and may hasten the onset of the late or end stages of the disease where cartilage may be totally destroyed, 
especially in cases of obesity, where excess mechanical load and/or adipokine release can serve to raise the level 
of destruction in both weight bearing and non weightbearing joints [3]. 
5. Treatment to Minimize Osteoarthritic Destruction 
In light of the complexity of the osteoarthritic process, treatments to minimize osteoarthritic cartilage destruction 
must be carefully conceived. In particular, because the disease process in OA is greatly influenced by the pre-
vailing status of the neuromuscular system and its ability to protect the joint and underlying subchondral bone, 
the role of biomechanics in the disease process cannot be ignored. Moreover, without careful consideration of 
how joint biomechanics influences articular cartilage viability, the likelihood is that focal treatments of the ar-
ticular tissue, carried out in isolation will fail to completely ameliorate the disease, and may not prevent its re-
occurrence at the same joint or distant joints with time. For example, given the physiological dependence of 
normal chondrocyte physiology on extrinsic factors such as joint motion and joint loading which facilitates car-
tilage nutrition, transplantation of cartilagenous tissue, resurfacing of affected joints or restoration of articular 
surfaces using growth factors and other methods of stimulating cartilage is bound to have no durable effect, if 
joint deformities and capsular contractures persist, muscle strength and coordination is suboptimal, and joint 
laxity remains excessive or and untreated. The same idea would apply to the application of cartilage implants, or 
targeted cell-mediated gene transfer, which would ideally combine a supply of chondroprogenitor cells with the 
production of therapeutic factors directly at the lesion site [49]. Moreover, to be optimally effective in the case 
of implants, the structural heterogeneity of articular tissue at the cellular level would not only have to be pre-
cisely reproduced in three-dimensions, but also very carefully mapped to the configuration of any defective re-
gion(s).   
In addition, even with some form of enzymatic control, in the face of continued cartilage fragmentation, and 
or cell membrane damage it is difficult to see how all immunogenic or related apoptotic responses and those in-
volving production of reactive oxygen and nitric acid radicals that can impair articular chondrocyte functions 
can be obviated. It is also not clear from the pathogenesis of the disease, what proteolytic enzymes might be 
targeted to reduce matrix catabolism, and for what durations? Likely candidates, the metalloproteinases, the cy-
tokine-interleukin-1, tumor necrosis factor alpha, lysosomes, the Cathepsins may need to be targeted differen-
tially or contemporaneously depending on disease stage and sites of destruction. Alternately, Roughly, Nguyen 
and Mort [44] found cartilage remaining in osteoarthritic joints did not show more extensive proteolysis than its 
normal counterpart. Evidence also shows that reducing inflammatory cytokine levels effects osteoarthritis sym- 
ptoms, but not the disease progression [42]. 
It is thus open to speculation whether antiiflammatory interventions or enzymatic blockers can prevent carti-
lage destruction in the long term, particularly upon cessation of their usage or in absence of any ongoing ana-
bolic reparative processes or any respite from abnormal loading. Indeed, as indicated by Sokoloff [45], OA may 
not be so much the inability of the articular surface to repair itself, but an aberration of the repair process result-
ing from persistent abnormal loading. 
Thus unless multiple therapeutic strategies including periods of rest so that damaged cartilage can rehydrate 
and mount a reparative process, from the earliest point in time, along with other biomechanical strategies, and 
these are not applied insightfully and consistently, possibly along with growth factors to enhance cell function, 
treatment will likely prove less than optimal. That is, if all sources of abnormal mechanical loading are not 
minimized and rendered as close to optimal as possible, all extra articular interventions, particularly those that 
may have the capacity to modulate chondrocyte synthetic mechanisms and biological resurfacing of damaged 
cartilage by new bone growth or implants are likely to fail. In addition, although Stockwell [29] has opined that 
OA has no systemic effects, the lack of mobility and dysfunction that usually accompanies untreated or inap-
propriately treated osteoarthritic joint disease can surely affect cardiovascular health as well as bone health det-
rimentally and therefore if unattended to may result in further damage, joint dysfunction, and immobility due to 
pain even if cell-based repair strategies are initially favorable. The use of various remedies applied in isolation 
to quell pain have largely failed as well [see review in citation 1], possibly because in the absence of pain, and 
no biomechanical intervention, more forceful or prolonged loading of the damaged joint causes more harm than 
good. 





molarity states that favor chondrocyte physiology, this potentially detrimental situation may be effectively obvi-
ated by interventions which reduce pain and joint loading but which encourage moderate forms of exercise and 
maintenance of joint mobility and sensibility. Since chondrocytes are also found to recover their normal protein 
synthesis when osmolarity of the surrounding fluid is reduced from any dangerously high osmolarity levels [40], 
interventions which reduce joint compressive forces, especially those which create focal joint stresses may prove 
especially helpful. Interventions which promote cell shape in its rounded form are also likely to promote main-
tenance of the phenotype [46] and possibly explain why efforts to apply distraction may prove highly beneficial 
to the osteoarthritic damaged joint. 
Finally, to reduce the overall burden of osteoarthritis, and enable biological and surgical as well as gene 
therapies to be efficacious, where desirable, multiple preventive strategies highlighted in Figure 4, are likely to 
prove beneficial for purposes of primary, secondary, as well as tertiary prevention, and should not be underesti-
mated in efforts to foster optimal joint function, across the lifespan, regardless of level of joint pathology. 
6. Conclusions 
Articular cartilage, covering the needs of freely moving joints is a highly active tissue and one that depends 
largely on mechanical stimuli for its growth and maintenance [47]. Aberrant loading, on the contrary, can lead to 
cartilage damage as supported by numerous loading studies ranging from immobilization to excessive weight-
bearing. 
Although less is known about the molecular mechanisms underlying these mechanical effects, recent studies 
from molecular biology and cell membrane signalling pathways suggest mechanical stimuli and others can acti-
vate cartilage cellular mechanisms differentially. 
In this regard, Qwing et al. [50] suggest that several factors are involved in the osteoarthritic disease process, 
including the degradation of proteoglycans, abnormal loading effects that may trigger an imbalance of chondro-
cyte anabolic and catabolic activities, and structural damage of the proteoglycans and collagen fibrils that trig-
gers an immunological reaction and consequently the accelerated degradation of proteoglycans. 
In terms of biomechanics, research shows cartilage tissue can remodel its extracellular matrix in response to 
alterations in functional demand, and that changes in the properties of the pericellulur matrix with osteoarthritis 
may alter the stress-strain and fluid-flow environment of chondrocytes as well as its loading features. Moreover, 
excessive compression that overloads the integrity of the cartilage matrix may in turn, and causes cell membrane 
damage and eventually cell death after which tumor necrosis factor and interleuken-1 foster stress-injury-related 
proteins release [51]. 
 
 
Figure 4. Suggested strategies to prevent abnormal joint loading and excess destruction in 





Given the poor capacity of articular cartilage for repair, and that millions of older adults suffer immense pain 
as a result of OA, and that treatments commonly directed to reduce pain may not focus on identifying the cause 
of the problem, a better understanding of the pathways that foster normal cartilage physiology as well as those 
that are potentially involved in mediating cartilage pathology is indicated. As pointed out by Aigner et al. [52] 
very often the primary targets of osteoarthritis therapy, the extracellular matrix and the cartilage chondrocytes, 
do not take into account other joint tissues that are also important for fostering the disease [45], or the movement 
patterns that lead to the disease or both and these elements are located outside the articular tissue. Although im-
plantation of mesenchymal stem cells [53] or gene therapy [54] or implantation therapy [55] have been advo-
cated, recent research further reveals that osteoarthritic chondrocytes may undergo genetic alterations that heigh- 
ten the release of degrading enzymes [56], and reactive oxygen species [57]. 
Moreover, autogenous osteochondral arthroscopically implanted grafts, or open implantation of lateral patel-
lar facet, requires violation of subchondral bone, risk of viral transmission of disease and low chondrocyte via-
bility, in addition to removal of host bone for implantation [58], even though bone integrity is vital to joint func-
tion, and is often believed to be the precursor of OA, rather than the outcome of this disorder. 
In addition, cellular implants may not be helpful if the heterogeneity of the chondrocytes is not accounted for, 
and severe structural changes in the extracellular matrix are not addressed. The chondrocytes may also display 
abnormalities during osteoarthritic cartilage degeneration, and may continue to be exposed to additional stimuli 
such as nonphysiologic loading conditions and byproducts of matrix destruction, as well as abnormal levels of 
cytokines and growth factors [59]. This exposure can lead to a structured cellular response pattern that may be 
highly detrimental to the cartilage tissue if not accounted for. Consequently, even if it appears cartilage tissue 
might serve as the key target for ameliorating this condition, the role of joint biomechanics and biomechanical 
transduction pathways and their relationship to OA processes cannot be ignored if treatments such as the im-
plantation of mesenchymal stem cells [53] or gene therapy [54] are to be helpful. That is surgical implantation 
designed to foster physiologic repair using mesenchymal stem cells or chondrocytes delivered surgically in an ex 
vivo-derived matrix, in vitro manipulation of cells with growth factors, would still be subject to the effects of in-
trinsic and extrinsic mechanical stimuli [58]. By envisioning how joint biomechanics can influence molecular 
events at the chondrocyte cell membrane level as well as at potential gene expression levels, which in turn in-
fluences cartilage composition and joint anatomy and physiology, researchers and clinicians will undoubtedly be 
in a better position to advance the state of the art of preventing and treating an osteoarthritic joint, as outlined by 
Brady et al. [60], notwithstanding the importance of considering the bone, and synovial tissues among others, 
and are encouraged to do so. All aging populations worldwide, who are at an especially high risk for this condi-
tion, given the prevalence of obesity, and sedentary lifestyles among adults today, as well as policy makers who 
must fund their needs, could be ably served in this regard. 
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